Protagonist Therapeutics Inc (PTGX)

Protagonist Therapeutics Inc Azioni (PTGX) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	324.92% 254.95	60.00	-	-	-
Operating Expenses	31.64% 48.64	36.95	38.33	42.35	36.02
Benefits Costs and Expenses	44.29	-	-	-	-
Costs And Expenses	44.29	-	-	-	-
Operating Income/Loss	795.09% 206.31	23.05	-38.33	-42.35	-36.02
Income/Loss From Continuing Operations Before Tax	670.68% 210.67	27.34	-34.10	-38.46	-33.73
Income Tax Expense/Benefit	3.326	-	-	-	-
Income/Loss From Continuing Operations After Tax	658.51% 207.34	27.34	-34.10	-38.46	-33.73
Net Income/Loss	658.51% 207.34	27.34	-34.10	-38.46	-33.73
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	4,884% 60.86	1.221	59.18	56.78	50.57
Diluted Average Shares	5,108% 63.60	1.221	59.18	56.78	50.57
Basic Earnings Per Share	555.77% 3.41	0.52	-0.58	-0.68	-0.67
Diluted Earnings Per Share	526.92% 3.26	0.52	-0.58	-0.68	-0.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-